Apparatus and methods for filling a drug eluting medical device via capillary action

Patent metadata

Field	Value
Publication number	US-9549832-B2
Application number	US-201213457398-A
Country	US
Kind code	B2
Filing date	Apr 26, 2012
Priority date	Apr 26, 2012
Publication date	Jan 24, 2017
Grant date	Jan 24, 2017

Abstract

Methods and apparatus are disclosed for filling a therapeutic substance or drug within a hollow wire that forms a stent. The stent is placed within a chamber housing a fluid drug formulation. During filling, the chamber is maintained at or near the vapor-liquid equilibrium of the solvent of the fluid drug formulation. To fill the stent, a portion of the stent is placed into contact with the fluid drug formulation until a lumenal space defined by the hollow wire is filled with the fluid drug formulation via capillary action. After filling is complete, the stent is retracted such that the stent is no longer in contact with the fluid drug formulation. The solvent vapor pressure within the chamber is reduced to evaporate a solvent of the fluid drug formulation. A wicking means may control transfer of the fluid drug formulation into the stent.

First claim

What is claimed is:

1. A method of filling a fluid drug formulation within a lumenal space of a hollow wire having a plurality of side openings along a length thereof openings that forms a stent, the method comprising the steps of:
placing a stent formed from a hollow wire having a plurality of side openings within a first chamber of an apparatus, wherein a pressure source is in fluid communication with the first chamber, wherein the apparatus includes a valve positioned between the first chamber and a second chamber that houses a means for wicking that is in contact with a fluid drug formulation and the valve is closed such that the first chamber and second chamber are not in fluid communication;
adjusting the pressure source to control the solvent vapor pressure within the first chamber;
opening the valve such that the first chamber and second chamber are in fluid communication;
allowing the first and second chambers to reach solvent vapor saturation;
placing a portion of the stent into contact with the means for wicking within the second chamber such that at least one of the plurality of side openings is in contact with the means for wicking;
maintaining contact between the means for wicking and a selected portion of the stent until a lumenal space defined by the hollow wire is filled with the fluid drug formulation via capillary action through the at least one of the plurality of side openings in contact with the means for wicking;
retracting the stent such that the portion of the stent is no longer in contact with the means for wicking and is located within the first chamber;
closing the valve such that the first chamber and second chamber are not in fluid communication; and
reducing a solvent vapor pressure in the first chamber to evaporate a solvent of the fluid drug formulation.

2. The method of claim 1 , wherein the step of allowing the first and second chambers to reach solvent vapor saturation includes atomizing droplets within the first and second chambers with an ultrasonic spray nozzle.

3. The method of claim 1 , wherein the step of allowing the first and second chambers to reach solvent vapor saturation includes increasing a temperature of the solvent.

4. The method of claim 1 , wherein the step of allowing the first and second chambers to reach solvent vapor saturation includes utilizing a fan to create convection across a reservoir filled within the solvent of the fluid drug formulation located within the first chamber.

5. The method of claim 1 , further comprising the step of:
allowing the first chamber to reach solvent vapor saturation with the valve closed such that the first chamber and second chamber are not in fluid communication, wherein the first chamber houses a reservoir filled with the solvent of the fluid drug formulation and the step of allowing the first chamber to reach solvent vapor saturation is performed after the step of placing the stent in the first chamber and prior to the step of opening the valve.

6. The method of claim 1 , wherein the step of retracting the stent such that the portion of the stent is no longer in contact with the means for wicking removes excess fluid drug formulation from an exterior surface of the hollow wire during the step of retracting the stent.

7. The method of claim 6 , wherein the wicking means is an open-celled sponge or foam.

8. The method of claim 6 , wherein the wicking means is a plurality of glass beads.

9. The method of claim 1 , wherein the step of reducing the solvent vapor pressure in the first chamber includes venting the first chamber back to ambient pressure.

Assignees

• Peterson Justin
• Mitchell James
• Schlichting Abby
• Glucklich Nate
• Berglund Joseph
• Guo Ya
• Medtronic Vascular Inc

Inventors

• Peterson Justin
• Mitchell James
• Schlichting Abby
• Glucklich Nate
• Berglund Joseph
• Guo Ya

Classifications

• A61F2/82

  Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07) · CPC title

• A61F2240/00

  Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof · CPC title

• A61F2250/0068

  the pharmaceutical product being in a reservoir · CPC title

• A61L2420/02

  Methods for coating medical devices · CPC title

• A61F2/91 Primary

  made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes · CPC title